- Home
- FRSX vs GLMD Comparison
FRSX vs GLMD Comparison
Compare FRSX & GLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRSX
- GLMD
- Stock Information
- Founded
- FRSX N/A
- GLMD 2000
- Country
- FRSX Israel
- GLMD Israel
- Employees
- FRSX N/A
- GLMD N/A
- Industry
- FRSX Computer Software: Prepackaged Software
- GLMD Biotechnology: Pharmaceutical Preparations
- Sector
- FRSX Technology
- GLMD Health Care
- Exchange
- FRSX Nasdaq
- GLMD Nasdaq
- Market Cap
- FRSX 8.2M
- GLMD 7.5M
- IPO Year
- FRSX 2017
- GLMD 2014
- Fundamental
- Price
- FRSX $2.46
- GLMD $1.51
- Analyst Decision
- FRSX
- GLMD Hold
- Analyst Count
- FRSX 0
- GLMD 1
- Target Price
- FRSX N/A
- GLMD N/A
- AVG Volume (30 Days)
- FRSX 65.8K
- GLMD 224.4K
- Earning Date
- FRSX 09-21-2025
- GLMD 08-28-2025
- Dividend Yield
- FRSX N/A
- GLMD N/A
- EPS Growth
- FRSX N/A
- GLMD N/A
- EPS
- FRSX N/A
- GLMD N/A
- Revenue
- FRSX $452,000.00
- GLMD N/A
- Revenue This Year
- FRSX N/A
- GLMD N/A
- Revenue Next Year
- FRSX N/A
- GLMD N/A
- P/E Ratio
- FRSX N/A
- GLMD N/A
- Revenue Growth
- FRSX N/A
- GLMD N/A
- 52 Week Low
- FRSX $2.17
- GLMD $1.15
- 52 Week High
- FRSX $18.41
- GLMD $23.80
- Technical
- Relative Strength Index (RSI)
- FRSX 46.67
- GLMD 53.20
- Support Level
- FRSX $2.30
- GLMD $1.33
- Resistance Level
- FRSX $2.63
- GLMD $1.63
- Average True Range (ATR)
- FRSX 0.20
- GLMD 0.11
- MACD
- FRSX 0.03
- GLMD 0.03
- Stochastic Oscillator
- FRSX 41.13
- GLMD 69.23
About FRSX Foresight Autonomous Holdings Ltd.
Foresight Autonomous Holdings Ltd is a technology company engaged in the design, development and commercialization of vision systems for the automotive industry. The company develops both in-line-of-sight vision systems and beyond-line-of-sight cellular-based applications through its wholly-owned subsidiaries. Its systems are designed to improve driving safety by enabling accurate and reliable threat detection while ensuring the lowest rates of false alerts. Foresight is pursuing several markets and believes its modern systems will revolutionize automotive safety by providing an automotive-grade, cost-effective platform.
About GLMD Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.